Mpox virus: Difference between revisions
From IDWiki
mNo edit summary |
|||
| Line 1: | Line 1: | ||
= |
= Microbiology = |
||
== Microbiology == |
|||
* Monkeypox virus (MPXV) is in the genus ''Orthopoxvirus'' and family ''Poxviridae'' |
* Monkeypox virus (MPXV) is in the genus ''Orthopoxvirus'' and family ''Poxviridae'' |
||
= Epidemiology = |
|||
* Zoonotic disease endemic to west and central Africa |
* Zoonotic disease endemic to west and central Africa |
||
| Line 14: | Line 12: | ||
* Human-to-human transmission possible, but less than smallpox |
* Human-to-human transmission possible, but less than smallpox |
||
= Clinical Presentation = |
|||
* Clinically indistinguishible from smallpox, though may have much more pronounced lymphadenopathy |
* Clinically indistinguishible from smallpox, though may have much more pronounced lymphadenopathy |
||
| Line 21: | Line 19: | ||
* Mortality 1-10% (per WHO) |
* Mortality 1-10% (per WHO) |
||
= Management = |
|||
== Post-exposure prophylaxis == |
|||
* ??smallpox vaccine?? |
* ??smallpox vaccine?? |
||
[[Category:Poxviridae] |
|||
Revision as of 11:16, 13 August 2019
Microbiology
- Monkeypox virus (MPXV) is in the genus Orthopoxvirus and family Poxviridae
Epidemiology
- Zoonotic disease endemic to west and central Africa
- Hosts include non-human primates and prairie dogs, squirrels, and possibly other rodents
- Endemic countries include DRC (most common), Liberia, Ivory Coast, Sierra Leone, Nigeria, Benin, Cameroon, Gabon, and South Sudan
- Human infection is associated with animal trapping, hunting, and skinning, and other exposures to animals including bites, feces, urine, or respiratory droplets
- Global outbreaks may happen with the global trafficking in exotic pets
- Human-to-human transmission possible, but less than smallpox
Clinical Presentation
- Clinically indistinguishible from smallpox, though may have much more pronounced lymphadenopathy
- Incubation period about 12 days
- Fever, rash, lymphadenopathy (cervical, submandibular, and sublingual)
- Mortality 1-10% (per WHO)
Management
Post-exposure prophylaxis
- ??smallpox vaccine??
[[Category:Poxviridae]
